News

Vesta remains a strong buy due to its 23.7% NAV per share undervaluation and resilient performance despite macroeconomic ...
Palantir Technologies Inc.'s stellar quarter signals growth potential. Click for why PLTR is a cautious buy for investors, ...
Corporate earnings have been strong, while the jobs report suggests a weaker economy. For the stock market, something’s gotta ...
Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.
Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...